文献速递免疫规划传染病防控与疫情报告

血清白蛋白纳米颗粒疫苗对致死性铜绿假单胞菌感染的保护作用

Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge.
PubMed 文献 · Vaccine · 2018-09-15

本研究在小鼠鼻腔感染模型中评价牛血清白蛋白纳米颗粒(BSA-NPs)偶联铜绿假单胞菌ATCC 27853总抗原(NPPa)的免疫保护效果。免疫后经鼻感染致死性PA14菌株,NPPa组48小时存活率最高、肺部细菌载量最低、细胞因子产生受控且组织病理改变少,提示该疫苗平台具开发前景。

要点

  • NPPa免疫小鼠在致死性PA14感染后存活率最高。
  • NPPa组肺部细菌载量最低,细胞因子产生受控,病理改变少。
  • 结果提示NPPa可诱导功能性免疫应答,为候选疫苗平台。

核心结论

  • NPPa免疫可保护小鼠抵抗致死性铜绿假单胞菌感染,促进肺部细菌清除并提高存活。
  • 该疫苗在致死性感染动物模型中诱导了功能性应答,是有前景的铜绿假单胞菌疫苗平台。

研究设计与样本

  • 研究用Swiss小鼠,设NPPa组、空纳米颗粒NPe组、ATCC 27853总抗原阳性对照组和PBS阴性对照组。
  • 免疫后经鼻感染铜绿假单胞菌PA14株,评估48小时存活率、肺部细菌载量、细胞因子表达和组织病理分析。

主要发现

  • 感染PA14后,NPPa免疫组存活率最高。
  • NPPa组肺部细菌载量最低,细胞因子产生受控,组织病理改变少。

临床怎么用

  • 原文结论为NPPa是有前景的铜绿假单胞菌疫苗平台,尚未提供临床转化或接种建议。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pseudomonas aeruginosa is an opportunistic pathogen that causes severe infections in immunocompromised individuals and in patients with cystic fibrosis. A range of vaccines to prevent infections caused by P. aeruginosa has already been tested, yet no vaccine against this pathogen is currently available. The goal of this study was to evaluate the potential of bovine serum albumin nanoparticles (BSA-NPs) associated with total P. aeruginosa ATCC 27853 antigens in inducing protection against the infection with virulent P. aeruginosa PA14 strain in murine model of nasal infection. Swiss mice were immunized with BSA-NPs associated with total P. aeruginosa antigens (NPPa) or empty NPs (NPe). As positive and negative control, groups of animals were immunized with total antigens of P. aeruginosa ATCC 27853 and phosphate buffered saline, respectively. Immunized mice were infected via nasal route using P. aeruginosa PA14 strain. The survival after 48 h was evaluated and the lungs from animals were processed for quantification of bacterial load, cytokine expression and histopathological analysis. After infection with P. aeruginosa PA14, animals immunized with NPPa had the highest survival rate, the lowest bacterial lung load, a controlled production of cytokines and few histopathological changes. These results indicate that NPPa immunization protected mice from infection, contributing for the elimination of the bacteria from the lungs, which consequently reflected the survival of the animals. Therefore, this vaccine was able to induce a functional response in an animal model of lethal infection and thereby is a promising platform for P. aeruginosa vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Maria de Souza Morais S, Ferreira Rodigues N, Ingrid Oliveira da Silva N, et al. Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge. Vaccine. 2018. PMID: 30228029. doi:10.1016/j.vaccine.2018.08.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。